Bristol-Myers Squibb Company believes that dissemination of information through independent medical education programs is a worthy undertaking. It is also important that independent medical education is objective, unbiased, balanced, scientifically rigorous, and not subject to sponsors' influence or control. Bristol-Myers Squibb follows the FDA Guidance on Industry-Supported Scientific and Educational Activities and the Standards for Commercial Support of Continuing Medical Education established by the Accreditation Council for Continuing Medical Education (ACCME) as well as other similar, recognized accrediting organizations, in addition to complying with the PhRMA Code on interactions with Healthcare Professionals. The independent medical education provider must be responsible for and retain complete control over the program, including the program structure, content, speakers, and invitation lists.

Periodically, Bristol-Myers Squibb will post open Requests for Proposals (RFPs) for Independent Medical Education programs. All responses must be received no later than eight weeks prior to the start date of this proposed program. In addition, responses must be received by the first Wednesday of the month in order to be eligible for review during that month.

• Atherothrombosis RFPs
• Diabetes RFPs
• Hypertension RFPs
• Immunoscience RFPs
• Neuroscience RFPs
• Oncology RFPs
  
• Thrombotic RFPs
• Virology RFPs